Ignite Creation Date:
2024-05-06 @ 6:59 PM
Last Modification Date:
2025-12-16 @ 9:33 PM
Study NCT ID:
NCT05852327
Status:
None
Last Update Posted:
2023-12-27 00:00:00
First Post:
2023-05-01 00:00:00
Brief Title:
Risk Stratifying COPD Exacerbations
Sponsor:
Pamela Youde Nethersole Eastern Hospital
Organization:
Pamela Youde Nethersole Eastern Hospital
Study Overview
Official Title:
Risk Stratifying COPD Exacerbations: a Prospective Study
Status:
None
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ProECOPD_23
Brief Summary:
Exacerbations of COPD (ECOPD) are heterogenous but are often considered as a single clinical entity. Clinical characteristics on presentation may predict outcome of patients with ECOPD.
DECAF score was previously proposed to predict in-hospital mortality but has not been validated in Asian subjects. ROME classification was recently proposed to better risk stratify ECOPD according to symptoms, physiological parameters and laboratory findings on admission, but no prospective validation study is available so far.
This study aims to identify clinical characteristics on presentation to predict outcome of patients with ECOPD.
DECAF score was previously proposed to predict in-hospital mortality but has not been validated in Asian subjects. ROME classification was recently proposed to better risk stratify ECOPD according to symptoms, physiological parameters and laboratory findings on admission, but no prospective validation study is available so far.
This study aims to identify clinical characteristics on presentation to predict outcome of patients with ECOPD.
Detailed Description:
Exacerbations of COPD ECOPD are heterogenous but are often considered as a single clinical entity Clinical characteristics on presentation may predict outcome of patients with ECOPD
DECAF score was previously proposed to predict in-hospital mortality but has not been validated in Asian subjects ROME classification was recently proposed to better risk stratify ECOPD according to symptoms physiological parameters and laboratory findings on admission but no prospective validation study is available so far
This study aims to identify clinical characteristics on presentation to predict outcome of patients with ECOPD
DECAF score was previously proposed to predict in-hospital mortality but has not been validated in Asian subjects ROME classification was recently proposed to better risk stratify ECOPD according to symptoms physiological parameters and laboratory findings on admission but no prospective validation study is available so far
This study aims to identify clinical characteristics on presentation to predict outcome of patients with ECOPD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None